Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Duo Wu
CONTACT
Lead
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
This study is a Phase Ib, open-label, multicentre study of SYN818 with Olaparib administered orally in patients with locally advanced or metastatic solid tumors harboring mutations in BRCA and/or defects in the homologous recombination repair (HRR) pathway
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
